Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	1.115
Sleep disorders - Primary central sleep apnea (G47.31)	823
Malignant neoplasm of bronchus and lung (C34.3)	635
Malignant neoplasm of bronchus and lung (C34.0)	540
Respiratory failure not elsewhere classified - Chronic respiratory failure with hypoxia (J96.11)	312
(J84.10)	192
Chronic obstructive pulmonary disease with acute lower respiratory infection (J44.00)	180
Malignant neoplasm of bronchus and lung (C34.8)	154
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs - Neoplasm of uncertain behavior of trachea bronchus and lung (D38.1)	147
Chronic obstructive pulmonary disease with acute exacerbation (J44.10)	138

Top 10 treatments

Treatment	Number
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	4.537
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	4.232
Examination of the bronchi by taking a sample of fluid or tissue with a needle (1-843)	2.855
Examination of the trachea and the bronchi by endoscopy (1-620.00)	2.765
Investigation of the of the brain, heart, and muscle activity, and respiration during sleep (1-790)	1.834
Examination of the trachea and the bronchi by endoscopy (1-620.10)	1.400
Six-minute walk test (as described by Guyatt) (1-715)	1.325
Ultrasound of the lungs with access through the respiratory tract (3-05f)	1.226
(9-984.7)	1.226
Taking a tissue sample (biopsy) of lymph nodes, spleen or thymus gland through the skin, guided by imaging procedures such as ultrasound (1-426.3)	1.193

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ03
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
60	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
20	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
20	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Participation in multi-centre Phase I/II studies
Doctoral supervision
Student training (clinical traineeship / internship year)